GlassScriptPhysician profile
Jaime Lee Stone
NPI 1417432303
$6,100.64
in general payments reported to CMS, 2019-2025
37 companies · $1,736 in 2025
The $1,736 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $988 · 2022: $1,558 · 2023: $958 · 2024: $862 · 2025: $1,736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,555.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,189.74 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $973.11 | 2022-2025 | |
| Novo Nordisk INC | $503.18 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $337.54 | 2021-2024 | Jardiance, Emgality, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $265.76 | 2022-2025 | Rexulti, Abilify Maintena |
| Glaxosmithkline, LLC. | $262.79 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $217.07 | 2021-2025 | Otezla, Repatha |
| Teva Pharmaceuticals USA, INC. | $200.61 | 2021-2025 | Ajovy, Austedo Xr |
| Amarin Pharma, INC. | $192.81 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $177.47 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $174.23 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $154.98 | 2021-2023 | Trintellix |
| Regeneron Healthcare Solutions, INC. | $148.76 | 2021-2023 | Dupixent |
| Novartis Pharmaceuticals Corporation | $125.21 | 2022-2023 | |
| Pfizer INC. | $110.98 | 2022-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.17 | 2021-2022 | |
| Astellas Pharma US INC | $101.25 | 2024-2025 | Veozah |
| Biohaven Pharmaceuticals, INC. | $95.05 | 2021 | |
| Merz North America, INC. | $84.69 | 2022 | |
| Eisai INC. | $77.12 | 2021-2022 | |
| Exact Sciences Corporation | $68.91 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Alkermes, INC. | $61.53 | 2022-2025 | Vivitrol, Vivitrol |
| Merck Sharp & Dohme LLC | $57.44 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $56.63 | 2025 | Fanapt |
| Mylan Specialty L.P. | $45.56 | 2024 | Yupelri |
| Baxter Healthcare | $42.88 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Janssen Pharmaceuticals, INC | $42.69 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $37.77 | 2022-2025 | Caplyta |
| Abbott Laboratories | $32.55 | 2022 | |
| Recordati_rare_diseases_inc. | $25.52 | 2025 | Isturisa |
| Lundbeck LLC | $22.05 | 2023 | Rexulti |
| Organon LLC | $21.02 | 2025 | Nexplanon |
| Dexcom, INC. | $19.20 | 2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $19.17 | 2022 | |
| Sanofi Pasteur INC. | $18.30 | 2022 | |
| Tandem Diabetes Care, INC. | $15.52 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Vbi Vaccine (Delaware) INC. | $15.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.